» Articles » PMID: 12391234

Increasing the Affinity of a Human IgG1 for the Neonatal Fc Receptor: Biological Consequences

Overview
Journal J Immunol
Date 2002 Oct 23
PMID 12391234
Citations 166
Authors
Affiliations
Soon will be listed here.
Abstract

Many biological functions, including control of the homeostasis and maternofetal transfer of serum gamma-globulins, are mediated by the MHC class I-related neonatal FcR (FcRn). A correlation exists in mice between the binding affinity of IgG1/Fc fragments to FcRn at pH 6.0 and their serum t(1/2). To expand this observation, phage display of mutagenized Fc fragments derived from a human IgG1 was used to increase their affinity to both murine and human FcRn. Ten variants were identified that have a higher affinity toward murine and human FcRn at pH 6.0, with DeltaDeltaG (DeltaG(wild type) - DeltaG(mutant)) from 1.0 to 2.0 kcal/mol and from 0.6 to 2.4 kcal/mol, respectively. Those variants exhibit a parallel increase in binding at pH 7.4 to murine, but not human, FcRn. Although not degraded in blood in vitro, accumulated in tissues, nor excreted in urine, their serum concentration in mice is decreased. We propose that higher affinity to FcRn at pH 7.4 adversely affects release into the serum and offsets the benefit of the enhanced binding at pH 6.0.

Citing Articles

Combinatorial Fc modifications for complementary antibody functionality.

Bartsch Y, Webb N, Burgess E, Kang J, Lauffenburger D, Julg B MAbs. 2025; 17(1):2465391.

PMID: 39950649 PMC: 11834420. DOI: 10.1080/19420862.2025.2465391.


GC1126A, a novel ADAMTS13 mutein, evades autoantibodies in immune-mediated thrombotic thrombocytopenic purpura.

Kwak H, Choi G, Kim S, Park J, Kwon Y, Lee Y Sci Rep. 2025; 15(1):1613.

PMID: 39794345 PMC: 11723924. DOI: 10.1038/s41598-024-80674-x.


Improving antibody-mediated protection against HSV infection by eliminating interactions with the viral Fc receptor gE/gI.

Slein M, Backes I, Kelkar N, Garland C, Khanwalkar U, Sholukh A bioRxiv. 2024; .

PMID: 39605495 PMC: 11601663. DOI: 10.1101/2024.11.20.624598.


A Brief Chronicle of Antibody Research and Technological Advances.

Araki K, Maeda R Antibodies (Basel). 2024; 13(4).

PMID: 39584990 PMC: 11587137. DOI: 10.3390/antib13040090.


Using IMGT unique numbering for IG allotypes and Fc-engineered variants of effector properties and half-life of therapeutic antibodies.

Lefranc M, Lefranc G Immunol Rev. 2024; 328(1):473-506.

PMID: 39367563 PMC: 11659927. DOI: 10.1111/imr.13399.